Literature DB >> 32930394

Pathological post-mortem findings in lungs infected with SARS-CoV-2.

Stefania Damiani1, Michelangelo Fiorentino2, Alessandra De Palma3, Maria Pia Foschini3, Tiziana Lazzarotto4, Liliana Gabrielli4, Pier Luigi Viale5, Luciano Attard5, Mattia Riefolo1, Antonia D'Errico1.   

Abstract

Italy was the first European nation to be massively infected by SARS-CoV-2. Up to the end of May 2020, more than 33,000 deaths had been recorded in Italy, with a large prevalence among males, those over 75 years of age, and in association with co-morbidities. We describe the lung pathological and immunohistochemical post-mortem findings at the autopsy of nine patients who died of SARS-CoV-2-associated disease. We found in the lung tissues of all patients histological changes consistent with diffuse alveolar damage in various evolution phases ranging from acute exudative to acute proliferative to fibrotic phase. Alveolar damage was associated with prominent involvement of the vascular component in both the interstitial capillaries and the mid-size vessels, with capillary fibrin micro-thrombi, as well as organized thrombi even in medium-sized arteries, in most cases not related to sources of embolism. Eosinophilic infiltrate was also seen, probably reactive to pharmacological treatment. Viral RNA of SARS-CoV-2 was detected from the lung tissues of all the nine patients. Immunohistochemistry for the receptor of the SARS-CoV-2, ACE2, and its priming activator TMPRSS2 revealed that both proteins co-localize in airway cells. In particular, the ACE2 protein was expressed in both endothelial cells and alveolar type I and II pneumocytes in the areas of histological diffuse alveolar damage (DAD). Pneumocytes, but not endothelial cells, also expressed TMPRSS2. There are no distinctive histological features of SARS-CoV-2 infection with respect to SARS-CoV-1 and other DAD with different aetiology. The identification of the cause of death in the course of SARS-CoV-2 infection is more likely multi-factorial.
© 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. © 2020 The Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  ACE2; COVID-19; SARS-CoV-2; TMPRSS2; coronavirus; infection; lung

Year:  2020        PMID: 32930394     DOI: 10.1002/path.5549

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  25 in total

1.  Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19.

Authors:  Courtney Tindle; MacKenzie Fuller; Ayden Fonseca; Sahar Taheri; Pradipta Ghosh; Soumita Das; Stella-Rita Ibeawuchi; Nathan Beutler; Gajanan Dattatray Katkar; Amanraj Claire; Vanessa Castillo; Moises Hernandez; Hana Russo; Jason Duran; Laura E Crotty Alexander; Ann Tipps; Grace Lin; Patricia A Thistlethwaite; Ranajoy Chattopadhyay; Thomas F Rogers; Debashis Sahoo
Journal:  Elife       Date:  2021-08-13       Impact factor: 8.140

2.  An ancient examination in the face of a modern pandemic: systematic review of major clinicopathological autopsy findings.

Authors:  Miguel Augusto Martins Pereira; Lucas Natã Lessa E Silva; Matheus Pires de Almeida Lessa; Jéssica Cunha; Ana Caroline Siquara de Souza; Luciana Pantaleão
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-08       Impact factor: 1.712

Review 3.  The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication.

Authors:  Qin Ning; Di Wu; Xiaojing Wang; Dong Xi; Tao Chen; Guang Chen; Hongwu Wang; Huiling Lu; Ming Wang; Lin Zhu; Junjian Hu; Tingting Liu; Ke Ma; Meifang Han; Xiaoping Luo
Journal:  Signal Transduct Target Ther       Date:  2022-02-23

4.  Unique inflammatory profile is associated with higher SARS-CoV-2 acute respiratory distress syndrome (ARDS) mortality.

Authors:  Joseph Balnis; Alejandro P Adam; Amit Chopra; Hau C Chieng; Lisa A Drake; Nina Martino; Ramon Bossardi Ramos; Paul J Feustel; Katherine A Overmyer; Evgenia Shishkova; Joshua J Coon; Harold A Singer; Marc A Judson; Ariel Jaitovich
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-01-12       Impact factor: 3.619

5.  Correlation of Krebs von den Lungen-6 and fibronectin with pulmonary fibrosis in coronavirus disease 2019.

Authors:  Ding-Hui Peng; Yi Luo; Li-Jun Huang; Fan-Lu Liao; Yan-Yuan Liu; Peng Tang; Han-Ning Hu; Wei Chen
Journal:  Clin Chim Acta       Date:  2021-02-22       Impact factor: 3.786

6.  Bacterial Superinfections Among Persons With Coronavirus Disease 2019: A Comprehensive Review of Data From Postmortem Studies.

Authors:  Cornelius J Clancy; Ilan S Schwartz; Brittany Kula; M Hong Nguyen
Journal:  Open Forum Infect Dis       Date:  2021-02-04       Impact factor: 3.835

7.  Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19.

Authors:  Peter A Szabo; Pranay Dogra; Joshua I Gray; Steven B Wells; Thomas J Connors; Stuart P Weisberg; Izabela Krupska; Rei Matsumoto; Maya M L Poon; Emma Idzikowski; Sinead E Morris; Chloé Pasin; Andrew J Yates; Amy Ku; Michael Chait; Julia Davis-Porada; Xinzheng V Guo; Jing Zhou; Matthew Steinle; Sean Mackay; Anjali Saqi; Matthew R Baldwin; Peter A Sims; Donna L Farber
Journal:  Immunity       Date:  2021-03-11       Impact factor: 31.745

Review 8.  Eosinophils and COVID-19: diagnosis, prognosis, and vaccination strategies.

Authors:  Helene F Rosenberg; Paul S Foster
Journal:  Semin Immunopathol       Date:  2021-03-16       Impact factor: 9.623

9.  Lung Ultrasound Patterns and Clinical-Laboratory Correlates during COVID-19 Pneumonia: A Retrospective Study from North East Italy.

Authors:  Riccardo Senter; Federico Capone; Stefano Pasqualin; Lorenzo Cerruti; Leonardo Molinari; Elisa Fonte Basso; Nicolò Zanforlin; Lorenzo Previato; Alessandro Toffolon; Caterina Sensi; Gaetano Arcidiacono; Davide Gorgi; Renato Ippolito; Enrico Nessi; Pietro Pettenella; Andrea Cellini; Claudio Fossa; Eleonora Vania; Samuele Gardin; Andi Sukthi; Dora Luise; Maria Teresa Giordani; Mirko Zanatta; Sandro Savino; Vito Cianci; Andrea Sattin; Anna Maria; Andrea Vianello; Raffaele Pesavento; Sandro Giannini; Angelo Avogaro; Roberto Vettor; Gian Paolo Fadini; Alois Saller
Journal:  J Clin Med       Date:  2021-03-20       Impact factor: 4.241

10.  The Long-Term Impact of COVID-19 Pneumonia on the Pulmonary Function of Survivors.

Authors:  Ayad Mohammed Salem; Noor Al Khathlan; Abdulelah Fawzi Alharbi; Turki Alghamdi; Saleh AlDuilej; Mohammed Alghamdi; Majed Alfudhaili; Ahmed Alsunni; Talay Yar; Rabia Latif; Nazish Rafique; Lubna Al Asoom; Hussein Sabit
Journal:  Int J Gen Med       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.